First Experience with de novo Calcineurin-Inhibitor-Free Immunosuppression Following Cardiac Transplantation
Open Access
- 21 January 2005
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (4), 827-831
- https://doi.org/10.1111/j.1600-6143.2005.00757.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Tacrolimus or Cyclosporine: Which Is the Better Partner for Mycophenolate Mofetil in Heart Transplant Recipients?Transplantation, 2004
- Sirolimus in combination with Tacrolimus for primary immunosuppression after heart transplantationThe Journal of Heart and Lung Transplantation, 2004
- Further analysis of the intravascular ultrasound data from the randomized mycophenolate mofetil (MMF) trial in heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2004
- Chronic Renal Failure after Transplantation of a Nonrenal OrganNew England Journal of Medicine, 2003
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the rapamune maintenance regimen study1 2Transplantation, 2003
- A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimusThe Journal of Heart and Lung Transplantation, 1999
- A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1Transplantation, 1998
- HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS TREATED WITH SIROLIMUS(RAPAMYCIN)Transplantation, 1998
- CYCLOSPORINE-ASSOCIATED END-STAGE NEPHROPATHY AFTER CARDIAC TRANSPLANTATIONTransplantation, 1997